Evidence map›Paper›PMID 42362867›Full record

Trial reportNature medicine2026

Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trial.

Ambrose Agweyu, Paul Mwaniki, Vaishnavi Menon, Robert Korom, Lynda Isaaka, Conrad Wanyama, Jaspret Gill, Sarah Kiptinness, Najib Adan, Mira Emmanuel-Fabula and 5 more

Abstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ambrose AgweyuKenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID http://orcid.org/0000-0001-8760-1279
Paul MwanikiKenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID http://orcid.org/0000-0003-0359-8426
Vaishnavi MenonDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Robert KoromPenda Health, Nairobi, Kenya.
Lynda IsaakaKenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.
Conrad WanyamaKenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID http://orcid.org/0000-0002-3553-6679
Jaspret GillDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Sarah KiptinnessPenda Health, Nairobi, Kenya.
Najib AdanPenda Health, Nairobi, Kenya.
Mira Emmanuel-FabulaDepartment of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0003-3117-767X
Richard D RileyDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Lucinda ArcherDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0003-2504-2613
Alastair K DennistonDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0001-7849-0087
Xiaoxuan LiuDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-1286-0038
Bilal A MateenDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. bmateen@path.org.ORCID http://orcid.org/0000-0003-4423-6472

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV-068056
6 · The paper itself

Abstract

Rigorous evidence on the performance of large language models (LLMs) in real-world, low-resource clinical settings remains limited. Here we conducted a pragmatic, cluster-randomized trial in 16 primary care facilities in Kenya. Clinical officers were randomized to use the electronic medical record with or without LLM assistance. The primary outcome was an expert-adjudicated composite of treatment failure events experienced within 14 days of enrollment. Between 22 April and 16 July 2025, 9,691 patients were enrolled, overseen by 103 clinical officers (52 in the LLM-assisted arm and 51 in the control arm). Treatment failure occurred in 102/4,693 patients (2.2%) in the intervention arm and 94/4,654 (2.0%) in the control arm (adjusted odds ratio 0.77, 95% confidence interval 0.55 to 1.08, P = 0.13). The primary outcome did not differ significantly between groups. No serious adverse events were judged related to the intervention, and independent review of the adverse events did not identify a safety signal. In this trial, LLM assistance was safe but did not reduce treatment failure within 14 days and any benefit, if present, is probably modest.Pan-African Clinical Trials Registry: 202502499779176.

Indexed as

Decision Support Systems, ClinicalPrimary Health CareAdultElectronic Health RecordsFemaleGenerative Artificial IntelligenceHumansKenyaLarge Language ModelsMale

Identifiers

PMID42362867
PMCPMC13472850

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.